BPG is committed to discovery and dissemination of knowledge
Featured Articles
4/17/2026 7:41:14 AM | Browse: 134 | Download: 293
 |
Received |
|
2025-11-05 06:07 |
 |
Peer-Review Started |
|
2025-11-05 06:07 |
 |
First Decision by Editorial Office Director |
|
2025-12-02 10:13 |
 |
Return for Revision |
|
2025-12-02 10:13 |
 |
Revised |
|
2025-12-19 06:19 |
 |
Publication Fee Transferred |
|
2025-12-26 11:50 |
 |
Second Decision by Editor |
|
2026-02-09 02:47 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-02-09 07:07 |
 |
Articles in Press |
|
2026-02-09 07:07 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2026-04-08 00:24 |
 |
Publish the Manuscript Online |
|
2026-04-17 07:16 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Modulation of the gut-liver axis by oxymatrine alleviates metabolic dysfunction-associated steatotic liver disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Fang Xiong, Ying He, Na Jiang, Yi-Hui Liu, Gao-Feng Chen, Chang-Qing Zhao, Shu-Yan Zhang, Yi-Jun Wu and Hong Xu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
No. 82074100 |
| Hangzhou Science and Technology Bureau |
No. 20201203B175 |
| Scientific Research Fund for TCM in Zhejiang Province |
No. 2023ZL551 |
| Scientific Research Fund for TCM in Zhejiang Province |
No. 2023ZL558 |
|
| Corresponding Author |
Hong Xu, Chief Physician, Department of Gastroenterology and Hepatology, Hangzhou Red Cross Hospital, No. 208 Huancheng Dong Road, Hangzhou 310003, Zhejiang Province, China. hongxuhzrc@aliyun.com |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; Alcoholic liver disease; Metabolic dysfunction-associated steatohepatitis; Insulin resistance; Oxidative stress |
| Core Tip |
Oxymatrine alleviates metabolic dysfunction-associated steatotic liver disease, primarily through modulation of the gut microbiome (increasing Lactobacillus, reducing Firmicutes/Bacteroidetes ratio) and the hepatic metabolome (increasing luteolin, decreasing adrenic acid). Fecal microbiota transplantation from oxymatrine donors recapitulated this protection, establishing a causal gut-liver axis for this natural alkaloid and offering a microbiota-guided therapeutic perspective. |
| Publish Date |
2026-04-17 07:16 |
| Citation |
Xiong JF, He Y, Jiang N, Liu YH, Chen GF, Zhao CQ, Zhang SY, Wu YJ, Xu H. Modulation of the gut-liver axis by oxymatrine alleviates metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2026; 32(16): 116187
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i16/116187.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i16.116187 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.